Interleukin-2 is upregulated in patients with a prolapsed lumbar intervertebral disc and modulates cell proliferation, apoptosis and extracellular matrix metabolism of human nucleus pulposus cells

Wang,Zhirong; Wang,Genlin; Zhu,Xuesong; Geng,Dechun; Yang,Huilin

doi:10.3892/etm.2015.2809

Interleukin-2 is upregulated in patients with a prolapsed lumbar intervertebral disc and modulates cell proliferation, apoptosis and extracellular matrix metabolism of human nucleus pulposus cells

Authors:
- Zhirong Wang
- Genlin Wang
- Xuesong Zhu
- Dechun Geng
- Huilin Yang
View Affiliations

Affiliations: Department of Orthopedic Surgery, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215006, P.R. China
Published online on: October 16, 2015 https://doi.org/10.3892/etm.2015.2809
Pages: 2437-2443

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Previous studies have demonstrated that the expression levels of cytokines are increased in degenerated intervertebral disc tissues, and several cytokines are associated with the pathogenesis of intervertebral disc degeneration. However, the role of interleukin (IL)‑2 in the cellular functions of intervertebral disc tissues remains unreported. The present study aimed to determine the expression levels of IL‑2 in the nucleus pulposus (NP) tissues of patients with a prolapsed lumbar intervertebral disc; and to observe the changes in cell proliferation, apoptosis, extracellular matrix (ECM) metabolism and p38 mitogen‑activated protein kinase (MAPK) signaling in human NP cells (HNPCs) following treatment with IL‑2. The present study demonstrated that IL‑2 expression levels were upregulated in the NP tissues of patients with a prolapsed lumbar intervertebral disc; and a subsequent MTT assay demonstrated that IL‑2 inhibits the proliferation of HNPCs in a dose‑dependent manner. Furthermore, as demonstrated by the increased protein expression levels of Fas cell surface death receptor and the induction of caspase‑8 and caspase‑3 activity, the death receptor pathway was activated by IL‑2 in the HNPCs in order to promote cell apoptosis. In addition, IL‑2 promoted ECM degradation in the HNPCs, as demonstrated by an increase in the expression levels of type I collagen, a disintegrin and metalloproteinase with thrombospondin motifs and matrix metalloproteinases, and decreased aggrecan and type II collagen expression levels. Furthermore, phosphorylated‑p38 was significantly increased in the HNPCs following IL‑2 treatment. In conclusion, the present study demonstrated that IL‑2 inhibits cell proliferation, and induces cell apoptosis and ECM degradation, accompanied by the activation of p38 MAPK signaling in HNPCs. Therefore, IL-2 may be a potential therapeutic agent for the treatment of degenerative disc disease.

View Figures

View References

1	Miller JA, Schmatz C and Schultz AB: Lumbar disc degeneration: Correlation with age, sex, and spine level in 600 autopsy specimens. Spine (Phila Pa 1976). 13:173–178. 1988. View Article : Google Scholar : PubMed/NCBI
2	Smith LJ, Nerurkar NL, Choi KS, Harfe BD and Elliott DM: Degeneration and regeneration of the intervertebral disc: Lessons from development. Dis Model Mech. 4:31–41. 2011. View Article : Google Scholar : PubMed/NCBI
3	Adams MA and Roughley PJ: What is intervertebral disc degeneration, and what causes it? Spine (Phila Pa 1976). 31:2151–2161. 2006. View Article : Google Scholar : PubMed/NCBI
4	Risbud MV and Shapiro IM: Role of cytokines in intervertebral disc degeneration: Pain and disc content. Nat Rev Rheumatol. 10:44–56. 2014. View Article : Google Scholar : PubMed/NCBI
5	Wang J, Markova D, Anderson DG, Zheng Z, Shapiro IM and Risbud MV: TNF-α and IL-1β promote a disintegrin-like and metalloprotease with thrombospondin type I motif-5-mediated aggrecan degradation through syndecan-4 in intervertebral disc. J Biol Chem. 286:39738–39749. 2011. View Article : Google Scholar : PubMed/NCBI
6	Shamji MF, Setton LA, Jarvis W, So S, Chen J, Jing L, Bullock R, Isaacs RE, Brown C and Richardson WJ: Proinflammatory cytokine expression profile in degenerated and herniated human intervertebral disc tissues. Arthritis Rheum. 62:1974–1982. 2010.PubMed/NCBI
7	Kołodziejska-Sawerska A, Rychlik A, Depta A, Wdowiak M, Nowicki M and Kander M: Cytokines in canine inflammatory bowel disease. Pol J Vet Sci. 16:165–171. 2013.PubMed/NCBI
8	Shachar I and Karin N: The dual roles of inflammatory cytokines and chemokines in the regulation of autoimmune diseases and their clinical implications. J Leukoc Biol. 93:51–61. 2013. View Article : Google Scholar : PubMed/NCBI
9	Karli P, Martlé V, Bossens K, Summerfield A, Doherr MG, Turner P, Vandevelde M, Forterre F and Henke D: Dominance of chemokine ligand 2 and matrix metalloproteinase-2 and −9 and suppression of pro-inflammatory cytokines in the epidural compartment after intervertebral disc extrusion in a canine model. Spine J. 14:2976–2984. 2014. View Article : Google Scholar : PubMed/NCBI
10	Akyol S, Eraslan BS, Etyemez H, Tanriverdi T and Hanci M: Catabolic cytokine expressions in patients with degenerative disc disease. Turk Neurosurg. 20:492–499. 2010.PubMed/NCBI
11	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
12	Minogue BM, Richardson SM, Zeef LA, Freemont AJ and Hoyland JA: Characterization of the human nucleus pulposus cell phenotype and evaluation of novel marker gene expression to define adult stem cell differentiation. Arthritis Rheum. 62:3695–3705. 2010. View Article : Google Scholar : PubMed/NCBI
13	McCann MR, Bacher CA and Séguin CA: Exploiting notochord cells for stem cell-based regeneration of the intervertebral disc. J Cell Commun Signal. 5:39–43. 2011. View Article : Google Scholar : PubMed/NCBI
14	Le Maitre CL, Hoyland JA and Freemont AJ: Catabolic cytokine expression in degenerate and herniated human intervertebral discs: IL-1beta and TNFalpha expression profile. Arthritis Res Ther. 9:R772007. View Article : Google Scholar : PubMed/NCBI
15	Deyo RA and Tsui-Wu YJ: Descriptive epidemiology of low-back pain and its related medical care in the United States. Spine (Phila Pa 1976). 12:264–268. 1987. View Article : Google Scholar : PubMed/NCBI
16	Buckwalter JA: Aging and degeneration of the human intervertebral disc. Spine (Phila Pa 1976). 20:1307–1314. 1995.PubMed/NCBI
17	Chen JW, Ni BB, Li B, Yang YH, Jiang SD and Jiang LS: The responses of autophagy and apoptosis to oxidative stress in nucleus pulposus cells: Implications for disc degeneration. Cell Physiol Biochem. 34:1175–1189. 2014. View Article : Google Scholar : PubMed/NCBI
18	Gruber HE and Hanley EN Jr: Biologic strategies for the therapy of intervertebral disc degeneration. Expert Opin Biol Ther. 3:1209–1214. 2003. View Article : Google Scholar : PubMed/NCBI
19	Zhao CQ, Jiang LS and Dai LY: Programmed cell death in intervertebral disc degeneration. Apoptosis. 11:2079–2088. 2006. View Article : Google Scholar : PubMed/NCBI
20	Zhao CQ, Wang LM, Jiang LS and Dai LY: The cell biology of intervertebral disc aging and degeneration. Ageing Res Rev. 6:247–261. 2007. View Article : Google Scholar : PubMed/NCBI
21	Chen YF, Zhang YZ, Zhang WL, Luan GN, Liu ZH, Gao Y, Wan ZY, Sun Z, Zhu S, Samartzis D, et al: Insights into the hallmarks of human nucleus pulposus cells with particular reference to cell viability, phagocytic potential and long process formation. Int J Med Sci. 10:1805–1816. 2013. View Article : Google Scholar : PubMed/NCBI
22	Jiang L, Zhang X, Zheng X, Ru A, Ni X, Wu Y, Tian N, Huang Y, Xue E, Wang X and Xu H: Apoptosis, senescence, and autophagy in rat nucleus pulposus cells: Implications for diabetic intervertebral disc degeneration. J Orthop Res. 31:692–702. 2013. View Article : Google Scholar : PubMed/NCBI
23	Zeng S, Liu L and Wang J: Significance of BNIP3 gene expression and cell apoptosis in nucleus pulposus of degenerative intervertebral disc in rabbits. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 24:1367–1371. 2010.(In Chinese). PubMed/NCBI
24	Yurube T, Hirata H, Kakutani K, Maeno K, Takada T, Zhang Z, Takayama K, Matsushita T, Kuroda R, Kurosaka M and Nishida K: Notochordal cell disappearance and modes of apoptotic cell death in a rat tail static compression-induced disc degeneration model. Arthritis Res Ther. 16:R312014. View Article : Google Scholar : PubMed/NCBI
25	Erwin WM and Hood KE: The cellular and molecular biology of the intervertebral disc: A clinician's primer. J Can Chiropr Assoc. 58:246–257. 2014.PubMed/NCBI
26	Sivan SS, Hayes AJ, Wachtel E, Caterson B, Merkher Y, Maroudas A, Brown S and Roberts S: Biochemical composition and turnover of the extracellular matrix of the normal and degenerate intervertebral disc. Eur Spine J. 23(Suppl 3): S344–S353. 2014. View Article : Google Scholar : PubMed/NCBI
27	Antoniou J, Demers CN, Beaudoin G, Goswami T, Mwale F, Aebi M and Alini M: Apparent diffusion coefficient of intervertebral discs related to matrix composition and integrity. Magn Reson Imaging. 22:963–972. 2004. View Article : Google Scholar : PubMed/NCBI
28	Antoniou J, Steffen T, Nelson F, Winterbottom N, Hollander AP, Poole RA, Aebi M and Alini M: The human lumbar intervertebral disc: Evidence for changes in the biosynthesis and denaturation of the extracellular matrix with growth, maturation, ageing, and degeneration. J Clin Invest. 98:996–1003. 1996. View Article : Google Scholar : PubMed/NCBI
29	Pritzker KP: Aging and degeneration in the lumbar intervertebral disc. Orthop Clin North Am. 8:66–77. 1977.PubMed/NCBI
30	Pockert AJ, Richardson SM, Le Maitre CL, Lyon M, Deakin JA, Buttle DJ, Freemont AJ and Hoyland JA: Modified expression of the ADAMTS enzymes and tissue inhibitor of metalloproteinases 3 during human intervertebral disc degeneration. Arthritis Rheum. 60:482–491. 2009. View Article : Google Scholar : PubMed/NCBI
31	Arana CJ, Diamandis EP and Kandel RA: Cartilage tissue enhances proteoglycan retention by nucleus pulposus cells in vitro. Arthritis Rheum. 62:3395–3403. 2010. View Article : Google Scholar : PubMed/NCBI
32	Hamilton DJ, Pilliar RM, Waldman S and Kandel RA: Effect of circumferential constraint on nucleus pulposus tissue in vitro. Spine J. 10:174–183. 2010. View Article : Google Scholar : PubMed/NCBI
33	Le Maitre CL, Freemont AJ and Hoyland JA: Human disc degeneration is associated with increased MMP 7 expression. Biotech Histochem. 81:125–131. 2006. View Article : Google Scholar : PubMed/NCBI
34	Le Maitre CL, Pockert A, Buttle DJ, Freemont AJ and Hoyland JA: Matrix synthesis and degradation in human intervertebral disc degeneration. Biochem Soc Trans. 35:652–655. 2007. View Article : Google Scholar : PubMed/NCBI
35	MacLean JJ, Roughley PJ, Monsey RD, Alini M and Iatridis JC: In vivo intervertebral disc remodeling: Kinetics of mRNA expression in response to a single loading event. J Orthop Res. 26:579–588. 2008. View Article : Google Scholar : PubMed/NCBI
36	Studer RK, Aboka AM, Gilbertson LG, Georgescu H, Sowa G, Vo N and Kang JD: p38 MAPK inhibition in nucleus pulposus cells: A potential target for treating intervertebral disc degeneration. Spine (Phila Pa 1976). 32:2827–2833. 2007. View Article : Google Scholar : PubMed/NCBI